The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis

Abstract

ObjectiveEpidemiological studies have investigated the association between Parkinson disease (PD) occurrence and the risk of brain tumors, while the results remain controversial. We performed a meta-analysis to clarify the exact relationship between PD and brain tumors.MethodsA systematic literature search was conducted using PubMed, Embase, ScienceDirect and CBM (China Biology Medicine Disc) before February 2016. Eligible studies were those that reported risk estimates of brain tumors among patients with PD or vice versa. A random-effects model was used to calculate the pooled odds ratio (OR) of the outcomes. Subgroup analyses and sensitivity analysis were conducted to explore the potential sources of heterogeneity.ResultsIn total, eight studies involving 329,276 participants met our inclusion criteria. The pooled OR was 1.51 (95%CI 1.21–1.89), indicating that PD carried a higher risk of brain tumor. Analyses by temporal relationship found that the occurrence of brain tumor was significantly higher after the diagnosis of PD (OR 1.55, 95% CI 1.18–2.05), but not statistically significant before PD diagnosis (OR 1.21, 95%CI 0.93–1.58). Subgroup analysis showed that gender differences, ethnicity differences and the characteristic of the tumor (benign or malignant) did not make much change in the association between brain tumor and PD.ConclusionsOur meta-analysis collecting epidemiological studies suggested a positive association of PD with brain tumors, while the influence of anti-parkinson drugs and ascertainment bias could not be excluded. Further studies with larger sample size and more strict inclusion criteria should be conducted in the future.

Biological and Clinical Implications of Comorbidities in Parkinson’s Disease

“…While most of the studies suggest an overall negative association between PD and cancer, some studies have indicated the opposite. For example, several studies have reported that PD patients are at higher risk of developing brain tumors (Lin et al, 2015 ; Tang et al, 2016 ; Ye et al, 2016 ) and breast cancer in women (Olsen et al, 2005 ; Rugbjerg et al, 2012 ). Additionally, PD patients harboring a G2019S LRRK2 mutation have been shown to have higher cancer rates than non-mutation carriers, especially for hormonal-related cancers and breast cancer in women (Agalliu et al, 2015 ).…”

RF heating of deep brain stimulation implants in open-bore vertical MRI systems

“…There are several situations when patients with actively implanted DBS devices need MRI. A majority require it as a part of diagnostic workup for various conditions such as acute ischemic stroke or postoperative hemorrhage [25,41,42]. The second scenario involves postoperative evaluation to document electrode location.…”

A Novel Mutation in Brain Tumor Causes Both Neural Over-Proliferation and Neurodegeneration in AdultDrosophila

“…For example, mutations or deletions in the human E3-ubiquitin ligase-coding gene PARK2 that lead to increased levels of cyclin E and re-entry of the cell cycle, are associated with both, several malignancies and early onset Parkinson’s disease ( Morris et al 2010 ). Indeed, recent epidemiological studies have identified positive associations between Parkinson’s disease and an increased risk of malignant brain tumors ( Lin et al 2015 ; Ye et al 2016 ). brat chs flies may serve in the future as an excellent model to investigate the mechanisms that underlie both conditions and may open novel avenues for therapeutic strategies and more targeted treatments for both cancer and neurodegenerative disease.…”